GENTIAN DIAGNOSTICS ASA (GENT.OL) Fundamental Analysis & Valuation
OSL:GENT • NO0010748866
Current stock price
42.5 NOK
0 (0%)
Last:
This GENT.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GENT.OL Profitability Analysis
1.1 Basic Checks
- In the past year GENT was profitable.
- GENT had a positive operating cash flow in the past year.
- In multiple years GENT reported negative net income over the last 5 years.
- The reported operating cash flow has been mixed in the past 5 years: GENT reported negative operating cash flow in multiple years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 5.13%, GENT is in the better half of the industry, outperforming 69.84% of the companies in the same industry.
- The Return On Equity of GENT (6.47%) is comparable to the rest of the industry.
- Looking at the Return On Invested Capital, with a value of 8.73%, GENT is in the better half of the industry, outperforming 74.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.13% | ||
| ROE | 6.47% | ||
| ROIC | 8.73% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- GENT has a Profit Margin of 7.51%. This is in the better half of the industry: GENT outperforms 60.32% of its industry peers.
- Looking at the Operating Margin, with a value of 14.42%, GENT is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
- The Gross Margin of GENT (55.64%) is comparable to the rest of the industry.
- GENT's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.42% | ||
| PM (TTM) | 7.51% | ||
| GM | 55.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.99%
GM growth 5Y2.77%
2. GENT.OL Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GENT is still creating some value.
- There is no outstanding debt for GENT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- GENT has an Altman-Z score of 8.42. This indicates that GENT is financially healthy and has little risk of bankruptcy at the moment.
- GENT has a better Altman-Z score (8.42) than 93.65% of its industry peers.
- The Debt to FCF ratio of GENT is 0.61, which is an excellent value as it means it would take GENT, only 0.61 years of fcf income to pay off all of its debts.
- GENT has a better Debt to FCF ratio (0.61) than 93.65% of its industry peers.
- A Debt/Equity ratio of 0.09 indicates that GENT is not too dependend on debt financing.
- GENT has a better Debt to Equity ratio (0.09) than 80.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.61 | ||
| Altman-Z | 8.42 |
ROIC/WACC1.02
WACC8.53%
2.3 Liquidity
- A Current Ratio of 5.40 indicates that GENT has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 5.40, GENT belongs to the top of the industry, outperforming 96.83% of the companies in the same industry.
- GENT has a Quick Ratio of 3.81. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 3.81, GENT belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.4 | ||
| Quick Ratio | 3.81 |
3. GENT.OL Growth Analysis
3.1 Past
- GENT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -70.75%.
- The Revenue has grown by 16.07% in the past year. This is quite good.
- The Revenue has been growing by 22.75% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-70.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.41%
Revenue 1Y (TTM)16.07%
Revenue growth 3Y20.2%
Revenue growth 5Y22.75%
Sales Q2Q%9.35%
3.2 Future
- The Earnings Per Share is expected to grow by 79.21% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 19.00% on average over the next years. This is quite good.
EPS Next Y204.65%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
EPS Next 5YN/A
Revenue Next Year19.34%
Revenue Next 2Y20.77%
Revenue Next 3Y19%
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. GENT.OL Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 50.00, which means the current valuation is very expensive for GENT.
- Compared to the rest of the industry, the Price/Earnings ratio of GENT indicates a slightly more expensive valuation: GENT is more expensive than 61.90% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of GENT to the average of the S&P500 Index (27.53), we can say GENT is valued expensively.
- Based on the Price/Forward Earnings ratio of 15.90, the valuation of GENT can be described as correct.
- Based on the Price/Forward Earnings ratio, GENT is valued a bit cheaper than the industry average as 68.25% of the companies are valued more expensively.
- GENT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 37.95.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 50 | ||
| Fwd PE | 15.9 |
4.2 Price Multiples
- GENT's Enterprise Value to EBITDA ratio is in line with the industry average.
- GENT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. GENT is cheaper than 74.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.59 | ||
| EV/EBITDA | 16.46 |
4.3 Compensation for Growth
- GENT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as GENT's earnings are expected to grow with 79.21% in the coming years.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y113.5%
EPS Next 3Y79.21%
5. GENT.OL Dividend Analysis
5.1 Amount
- GENT has a Yearly Dividend Yield of 1.46%. Purely for dividend investing, there may be better candidates out there.
- In the last 3 months the price of GENT has falen by -27.47%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
- GENT's Dividend Yield is a higher than the industry average which is at 1.23.
- GENT's Dividend Yield is comparable with the S&P500 average which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.46% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 46.54% of the earnings are spent on dividend by GENT. This is a bit on the high side, but may be sustainable.
DP46.54%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
GENT.OL Fundamentals: All Metrics, Ratios and Statistics
OSL:GENT (4/17/2026, 11:38:23 AM)
42.5
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners39.64%
Inst Owner ChangeN/A
Ins Owners2.68%
Ins Owner ChangeN/A
Market Cap655.35M
Revenue(TTM)176.50M
Net Income(TTM)13.26M
Analysts85.71
Price Target64.26 (51.2%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.46% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP46.54%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-17.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 50 | ||
| Fwd PE | 15.9 | ||
| P/S | 3.71 | ||
| P/FCF | 20.59 | ||
| P/OCF | 15.39 | ||
| P/B | 3.2 | ||
| P/tB | 3.87 | ||
| EV/EBITDA | 16.46 |
EPS(TTM)0.85
EY2%
EPS(NY)2.67
Fwd EY6.29%
FCF(TTM)2.06
FCFY4.86%
OCF(TTM)2.76
OCFY6.5%
SpS11.45
BVpS13.29
TBVpS10.97
PEG (NY)0.24
PEG (5Y)N/A
Graham Number15.9437 (-62.49%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.13% | ||
| ROE | 6.47% | ||
| ROCE | 11.34% | ||
| ROIC | 8.73% | ||
| ROICexc | 16.54% | ||
| ROICexgc | 23.72% | ||
| OM | 14.42% | ||
| PM (TTM) | 7.51% | ||
| GM | 55.64% | ||
| FCFM | 18.03% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.99%
GM growth 5Y2.77%
F-Score6
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.61 | ||
| Debt/EBITDA | 0.56 | ||
| Cap/Depr | 118.04% | ||
| Cap/Sales | 6.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 123.21% | ||
| Profit Quality | 240.13% | ||
| Current Ratio | 5.4 | ||
| Quick Ratio | 3.81 | ||
| Altman-Z | 8.42 |
F-Score6
WACC8.53%
ROIC/WACC1.02
Cap/Depr(3y)95.7%
Cap/Depr(5y)120.92%
Cap/Sales(3y)5.54%
Cap/Sales(5y)9.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.41%
EPS Next Y204.65%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
EPS Next 5YN/A
Revenue 1Y (TTM)16.07%
Revenue growth 3Y20.2%
Revenue growth 5Y22.75%
Sales Q2Q%9.35%
Revenue Next Year19.34%
Revenue Next 2Y20.77%
Revenue Next 3Y19%
Revenue Next 5YN/A
EBIT growth 1Y61.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year128%
EBIT Next 3Y57.14%
EBIT Next 5YN/A
FCF growth 1Y1169.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y216.49%
OCF growth 3YN/A
OCF growth 5YN/A
GENTIAN DIAGNOSTICS ASA / GENT.OL Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.
Can you provide the valuation status for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a valuation rating of 5 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.
What is the profitability of GENT stock?
GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.
What are the PE and PB ratios of GENTIAN DIAGNOSTICS ASA (GENT.OL) stock?
The Price/Earnings (PE) ratio for GENTIAN DIAGNOSTICS ASA (GENT.OL) is 50 and the Price/Book (PB) ratio is 3.2.
What is the earnings growth outlook for GENTIAN DIAGNOSTICS ASA?
The Earnings per Share (EPS) of GENTIAN DIAGNOSTICS ASA (GENT.OL) is expected to grow by 204.65% in the next year.